Review
Published on 29 Sep 2025
Antibiotic-sparing strategies for multidrug-resistant organism (MDRO) infections
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1653424
- 928 views
Type at least 3 characters
414 articles
Original Research
Accepted on 26 Sep 2025
Febuxostat may decrease the incidence of COVID-19 infection among patients with gout: A Retrospective Cohort Study
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1654173
- 344 views
Review
Published on 26 Sep 2025
Small nucleic acid drugs-the dawn of functional cure of chronic hepatitis B
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1633001
- 1,549 views
Original Research
Published on 25 Sep 2025
Topical delivery of meropenem via spanlastic carbopol gel: in-vitro studies and in-vivo application in pressure ulcers
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1672677
- 922 views
Review
Published on 24 Sep 2025
Genomic variability and immunological aspects involved in response to MPXV infection
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1665830
- 1,621 views
Original Research
Published on 23 Sep 2025
β-tricalcium phosphate/calcium sulfate loaded with contezolid acefosamil (MRX-4) for antimicrobial potency, prevention and killing efficacy of MRSA biofilm
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1657099
- 1,307 views
Study Protocol
Accepted on 22 Sep 2025
Yiqi Gubiao Pill for Tuberculosis-Associated Obstructive Pulmonary Disease: Protocol for a Double-Blind Randomized Controlled Trial
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1610889
- 541 views
Original Research
Accepted on 22 Sep 2025
Optimizing Antifungal Dosing for Invasive Cryptococcus Infections: Minimum Inhibitory Concentration Distributions and Pharmacokinetic/Pharmacodynamic Insights from 2010–2023 Antimicrobial Testing Leadership and Surveillance Data
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1665253
- 350 views
Original Research
Accepted on 15 Sep 2025
GEODE: An in silico tool that translates in vitro to in vivo predictions of Tuberculosis antibiotic combination efficacy
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1639673
- 1,055 views
Original Research
Accepted on 15 Sep 2025
Antimicrobial activity of β-lactam antibiotics against pneumococcal isolates causing pneumococcal disease in adults immediately before and after the COVID-19 pandemic in Spain (2019-2020)
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1658431
- 323 views
Review
Accepted on 11 Sep 2025
Evaluating the Advancements and Efficacies in Pharmacological Mpox Treatments: A Comprehensive Review
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1654467
- 1,220 views
Original Research
Published on 11 Sep 2025
The role of curcumin in modulating nutritional status and susceptibility to Mycoplasma pneumoniae infection in children
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1651875
- 1,060 views
Original Research
Published on 11 Sep 2025
Antibacterial and wound healing effects of PEG-coated ciprofloxacin-loaded ZIF-8 nanozymes against ciprofloxacin-resistant Pseudomonas aeruginosa taken from burn wounds
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1556335
- 1,307 views
Editorial
Published on 10 Sep 2025
Editorial: Beyond traditional antibiotics: innovations in biologics, chemical modulators, and microbiome manipulation
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1679268
- 978 views
Original Research
Published on 10 Sep 2025
Real-world correlation between therapeutic drug monitoring and clinical outcomes of the antifungal drug posaconazole: a single-center retrospective cohort study
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1592767
- 1,372 views
Original Research
Published on 05 Sep 2025
Synthesis and biological activity evaluation of a novel pleuromutilin derivative 22-((2-methyl-1-(1H-pyrrole-2-carboxamido)propan-2-yl)thio)-deoxypleuromutilin
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1657973
- 1,112 views